These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 10439301

  • 1. [The characteristics of the development of cataleptic phenomena during the action of a new Ukrainian neuroleptic--a butyrophenone derivative--in experiments on mice].
    Shapovalova VO, Mykhaĭlov VS, Shapovalov VV.
    Fiziol Zh (1994); 1999; 45(3):114-7. PubMed ID: 10439301
    [Abstract] [Full Text] [Related]

  • 2. Effects of tryptophan and valine administration on behavioral pharmacology of haloperidol.
    Ali O, Haleem DJ, Saify ZS, Kamil N, Obaid R, Ahmed SW.
    Pak J Pharm Sci; 2005 Apr; 18(2):23-8. PubMed ID: 16431394
    [Abstract] [Full Text] [Related]

  • 3. Dosing time-dependent tolerance of catalepsy by repetitive administration of haloperidol in mice.
    Viyoch J, Ohdo S, Yukawa E, Higuchi S.
    J Pharmacol Exp Ther; 2001 Sep; 298(3):964-9. PubMed ID: 11504791
    [Abstract] [Full Text] [Related]

  • 4. A possible participation of gonadotropin-releasing hormone in the neuroleptic and cataleptic effect of haloperidol.
    Umathe SN, Wanjari MM, Manna SS, Jain NS.
    Neuropeptides; 2009 Jun; 43(3):251-7. PubMed ID: 19403167
    [Abstract] [Full Text] [Related]

  • 5. [The role of the genotype in the cataleptogenic effect of neuroleptics].
    Skrinskaia IuA, Nikulina EM, Popova NK.
    Eksp Klin Farmakol; 1992 Jun; 55(6):7-9. PubMed ID: 1363957
    [Abstract] [Full Text] [Related]

  • 6. Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol.
    Niemegeers CJ, Janssen PA.
    Arzneimittelforschung; 1974 Jan; 24(1):45-52. PubMed ID: 4406109
    [No Abstract] [Full Text] [Related]

  • 7. Contribution of the central histaminergic transmission in the cataleptic and neuroleptic effects of haloperidol.
    Jain NS, Tandi L, Verma L.
    Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):59-66. PubMed ID: 26455279
    [Abstract] [Full Text] [Related]

  • 8. Haloperidol-induced catalepsy is influenced by calcium channel antagonists.
    Biała G.
    Acta Pol Pharm; 2000 Dec; 57(3):233-7. PubMed ID: 11143713
    [Abstract] [Full Text] [Related]

  • 9. Differential tolerance to cataleptic effects of SCH 23390 and haloperidol after repeated administration.
    Lappalainen J, Hietala J, Syvälahti E.
    Psychopharmacology (Berl); 1989 Dec; 98(4):472-5. PubMed ID: 2570432
    [Abstract] [Full Text] [Related]

  • 10. Tolerance of haloperidol catalepsy.
    Ezrin-Waters C, Seeman P.
    Eur J Pharmacol; 1977 Feb 07; 41(3):321-7. PubMed ID: 556989
    [Abstract] [Full Text] [Related]

  • 11. Effect of alpha-methyl-p-tyrosine on neuroleptic-induced catalepsy in rat.
    Gada VP, Nandal NV, Balsara JJ, Chandorkar AG.
    Indian J Physiol Pharmacol; 1983 Feb 07; 27(3):241-4. PubMed ID: 6141998
    [Abstract] [Full Text] [Related]

  • 12. [Hyperprolactinemia and catalepsy induced by haloperidol].
    Reggio A, Condorelli DF, De Simone D, Giammona G, Maccagnano C, Panico AM, Tigano G.
    Boll Soc Ital Biol Sper; 1981 Aug 30; 57(16):1655-9. PubMed ID: 7197982
    [Abstract] [Full Text] [Related]

  • 13. Droperidol concentrations at onset of catalepsy in rats.
    Rana J, Ramzan I, Baker AB.
    Pharmazie; 2004 Mar 30; 59(3):235-6. PubMed ID: 15074603
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic potential of alpha2 adrenoceptor antagonism for antipsychotic-induced extrapyramidal motor disorders.
    Imaki J, Mae Y, Shimizu S, Ohno Y.
    Neurosci Lett; 2009 Apr 24; 454(2):143-7. PubMed ID: 19429072
    [Abstract] [Full Text] [Related]

  • 15. [Minute rhythms of haloperidol catalepsy in rats].
    Arushanian EB, Popova AP.
    Biull Eksp Biol Med; 1986 Jan 24; 101(1):89-91. PubMed ID: 3942822
    [Abstract] [Full Text] [Related]

  • 16. Epinephrine potentiates antipsychotic, but not cataleptogenic effect of haloperidol in rats.
    Gmiro VE, Serdyuk SE.
    Bull Exp Biol Med; 2007 May 24; 143(5):617-9. PubMed ID: 18239784
    [Abstract] [Full Text] [Related]

  • 17. [Lithium modifications of the cataleptogenic properties of various neuroleptic drugs in the rat].
    Dessaigne S, Scotto AM, Guigues M.
    C R Seances Soc Biol Fil; 1978 May 24; 172(6):1173-80. PubMed ID: 40676
    [Abstract] [Full Text] [Related]

  • 18. Identification of quantitative trait loci for haloperidol-induced catalepsy on mouse chromosome 14.
    Rasmussen E, Cipp L, Hitzemann R.
    J Pharmacol Exp Ther; 1999 Sep 24; 290(3):1337-46. PubMed ID: 10454512
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical evidence for the involvement of gonadotropin releasing hormone in neuroleptic and cataleptic effects of haloperidol in mice.
    Fegade HA, Umathe SN.
    Neuropeptides; 2016 Apr 24; 56():89-96. PubMed ID: 26706182
    [Abstract] [Full Text] [Related]

  • 20. [The comparative characteristics of the spectrum of the pharmacological action of azaleptin and GCh-46].
    Tregubov AL, Kolla VE.
    Eksp Klin Farmakol; 1995 Apr 24; 58(2):19-21. PubMed ID: 7773080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.